Statin-Related Muscle Complaints: An Underestimated Risk Alberto Corsini Editorial 31 January 2006 Pages: 379 - 381
Effect of Matrix Metalloproteinase Inhibition by Doxycycline on Myocardial Healing and Remodeling after Myocardial Infarction Ariel TessoneMicah S. FeinbergJonathan Leor Basic Pharmacology 31 January 2006 Pages: 383 - 390
Effects of Long-Term Treatment with Candesartan on Hemodynamics and Organ Damage in Spontaneously Hypertensive Rats He-Hui XieYuan-Yuan ChenDing-Feng Su Basic Pharmacology 31 January 2006 Pages: 391 - 397
Levosimendan Use Reduces Matrix Metalloproteinase-2 in Patients with Decompensated Heart Failure Dimitrios N. TziakasGeorgios K. ChalikiasJuan Carlos Kaski Clinical Pharmacology Drug Study (Short Communication) 31 January 2006 Pages: 399 - 402
Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study Eric BruckertGilles HayemBernard Bégaud Clinical Trials 31 January 2006 Pages: 403 - 414
Strategies for Modifying High-Density Lipoprotein Cholesterol: A Role for Nicotinic Acid Michael Schachter Review 31 January 2006 Pages: 415 - 422
Ca2+-Sensitisers—A Promising Option to Treat Heart Failure? Klara BrixiusHeike Katharina HoyerRobert H. G. Schwinger Review 31 January 2006 Pages: 423 - 428
Multidisciplinary Vascular Screening Program Modestly Improves the Medical Treatment of Vascular Risk Factors B. M. B. GoessensF. L. J. VisserenY. van der Graaf Managed care 31 January 2006 Pages: 429 - 435
Being Well-Informed About Statin is Associated with Continuous Adherence and Reaching Targets Mehmet Birhan YilmazMurat PinarErsoy Isik Patient Education 31 January 2006 Pages: 437 - 440